SOMNOMED LIMITED
ASX: SOM
SomnoMed Ltd. engages in the production and sale of devices for the oral treatment of sleep related disorders. Its products include SomnoDent, SomMorning Repositioner, SomnoBrux, SomTabs, and Sunrise Sleep Test. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded in 2004 and is headquartered in S
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Healthcare Pulse Report
A$1200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Healthcare Pulse Report
Stay informed on Australia's healthcare sector with expert research covering healthcare, biotechnology, medical technology, and life sciences companies listed on the ASX.
- ✓ ASX Healthcare & Biotech Research
- ✓ Delivered Fortnightly every 2nd & 4th Tuesday
- ✓ Industry Trends & Risk Analysis
- ✓ Full Historical Report Access
A$1200.00/ 12 months
Risk:High
Subscribe Now →
